moxalactam has been researched along with Pseudomonas Infections in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (94.74) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barza, M; Murphy, TF | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
Caparosa, R; Haverkos, HW; Kamerer, D; Yu, VL | 1 |
Johnson, CE; Pennington, JE; Platt, R | 1 |
Giger, DK; Goering, RV; Penn, RG; Preheim, LC; Sanders, CC | 1 |
Fitzpatrick, SB; Rosenstein, BJ | 1 |
Slack, MP | 1 |
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
Aronoff, SC; Blumer, JL; Husak, M; Kelley, F; Reed, MD; Scoles, PV | 1 |
Bodey, GP; Bolivar, R; Elting, L; Fainstein, V; Keating, MJ; McCredie, KB | 1 |
Yu, VL | 1 |
Busuttil, RW; Kurtz, TO; Winston, DJ; Young, LS | 1 |
Love, JT; Mader, JT | 1 |
Hajsig, D; Skalova, R; Smerdel, S | 1 |
Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
DeMaria, A; McCabe, WR | 1 |
De Schepper, PJ; Mullie, A; Tjandramaga, TB; Van Hecken, A; Verbesselt, R; Verbist, L | 1 |
Fujii, M; Fukuyama, T; Nakano, T; Okamoto, K; Okuno, H | 1 |
Aswapokee, N; Aswapokee, P; Kobwantanakun, S; Pruksachartvutti, S | 1 |
1 review(s) available for moxalactam and Pseudomonas Infections
Article | Year |
---|---|
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
1 trial(s) available for moxalactam and Pseudomonas Infections
Article | Year |
---|---|
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
17 other study(ies) available for moxalactam and Pseudomonas Infections
Article | Year |
---|---|
Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections.
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas Infections | 1982 |
Gram-negative bacillary meningitis. New therapy and changing concepts.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Chloramphenicol; Enterobacteriaceae Infections; Humans; Meningitis; Moxalactam; Pseudomonas Infections | 1982 |
Moxalactam therapy. Its use in chronic suppurative otitis media and malignant external otitis.
Topics: Aged; Cephalosporins; Cephamycins; Chronic Disease; Diabetes Complications; Female; Humans; Male; Mastoiditis; Middle Aged; Moxalactam; Otitis Externa; Otitis Media; Otitis Media, Suppurative; Pseudomonas Infections | 1982 |
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1982 |
Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections | 1982 |
Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Male; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 1983 |
Evaluation of latamoxef as initial therapy of bone and joint infections in childhood.
Topics: Adolescent; Arthritis, Infectious; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Kinetics; Male; Microbial Sensitivity Tests; Moxalactam; Osteomyelitis; Pseudomonas Infections; Staphylococcal Infections | 1984 |
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Escherichia coli Infections; Female; Fever; Humans; Klebsiella Infections; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Moxalactam; Neutropenia; Pseudomonas Infections; Sarcoma; Ticarcillin; Tobramycin | 1984 |
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas Infections | 1981 |
Moxalactam therapy for bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1981 |
Malignant external otitis. Cure with adjunctive hyperbaric oxygen therapy.
Topics: Cephamycins; Diabetes Complications; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Moxalactam; Otitis Externa; Pseudomonas Infections | 1982 |
Interaction of moxalactam and gentamicin: in-vitro study with strains of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Cephalosporins; Cephamycins; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1982 |
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections | 1984 |
A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli.
Topics: Adult; Aged; Drug Evaluation; Enterobacteriaceae Infections; Female; Haemophilus Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam; Pneumonia; Pseudomonas Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections; Wound Infection | 1984 |
Comparative pharmacokinetics of ceftazidime and moxalactam.
Topics: Adult; Biological Availability; Ceftazidime; Drug Tolerance; Enterobacteriaceae Infections; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney; Kinetics; Male; Moxalactam; Pseudomonas Infections | 1982 |
[A case of hematuria associated with cefem group antibiotics].
Topics: Aged; Candidiasis; Hematuria; Humans; Male; Moxalactam; Pneumonia; Pneumonia, Viral; Pseudomonas Infections | 1992 |
Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas Infections | 1985 |